Data from: Spillage and food dust do not decrease efficacy of long-lasting insecticide-incorporated netting against stored product insects حسب Sabita Ranabhat (17484660)

Shows the 5′ region and the exons of the <i>C3</i> gene in the vertical line and the three new SNPs that we found by sequencing. حسب Yonghui Wang (287491)

Demographic, anthropometric, mobility, health, and cognitive characteristics of the participants (N = 50). حسب Sirinun Boripuntakul (13994171)

European Credit Transfer System grades (ECTS) (A) and highest educational level (B) according to test scores. حسب Anders H. Hjulmand (18476019)

Change from baseline (T0) to 6-month follow-up (T1), by naive status. حسب Nicola Squillace (691608)

Nuclear translocation of β-catenin in WT MHEC decreases during early phase of <i>T</i>. <i>cruzi</i> infection. حسب Ashutosh Arun (2574559)

S6 File - حسب Michelle Dey (525235)

First-in-Class Hydrazide-Based HDAC6 Selective Inhibitor with Potent Oral Anti-Inflammatory Activity by Attenuating NLRP3 Inflammasome Activation حسب Kairui Yue (11874403)

"…Structure–activity relationship study reveals that ethyl group substituent hydrazide-based ZBG and cap group with more substantial rigidity and larger volume increase the HDAC6 selectivity of designed compounds. Representative inhibitor <b>35m</b> exhibits potent HDAC6 inhibitory activity with an IC₅₀ value of 0.019 μM. …"

First-in-Class Hydrazide-Based HDAC6 Selective Inhibitor with Potent Oral Anti-Inflammatory Activity by Attenuating NLRP3 Inflammasome Activation حسب Kairui Yue (11874403)

"…Structure–activity relationship study reveals that ethyl group substituent hydrazide-based ZBG and cap group with more substantial rigidity and larger volume increase the HDAC6 selectivity of designed compounds. Representative inhibitor <b>35m</b> exhibits potent HDAC6 inhibitory activity with an IC₅₀ value of 0.019 μM. …"

Serum levels of IgG and IgM antibodies determined at baseline (T0), month 3 (T3), month 6 (T6) and month 12 (T12). حسب Domenico Maurizio Toraldo (9071920)

Temperature variability calculation for lags 0–6 for an example MI event on December 4. حسب Wenli Ni (5720498)

الموضوعات:

Cytokines profiles stratified by areas according to age in months. IL-10 level decreased when age increased in rural area. IL-10/TNF-alpha ratio increased with age in rural area bu... حسب Noé Patrick M’Bondoukwé (12419221)

Decrease in growth temperature results in elevated H2-T6SS and H3-T6SS promoter activity, while H1-T6SS promoter activity is decreased in mutant strains altered in the Gac/Rsm regu... حسب Marta Rudzite (15991136)

Both BCL6 inhibition by dominant negative BCL6 and blockade of lateral groove decreased viability and clonogenic potential. حسب Marie-Sophie Fabre (4413481)

Advancing the science of NOWS research. حسب Sarah E. Maylott (14560785)

"…Understanding which infants will develop NOWS soon after birth could reduce hospital stays for infants who do not develop NOWS and decrease burdens on hospitals and clinicians. We propose noninvasive clinical indicators of NOWS, including newborn neurobehavior, autonomic biomarkers, prenatal substance exposures, and socioeconomic environments. …"

Protocol measures. حسب Sarah E. Maylott (14560785)

"…Understanding which infants will develop NOWS soon after birth could reduce hospital stays for infants who do not develop NOWS and decrease burdens on hospitals and clinicians. We propose noninvasive clinical indicators of NOWS, including newborn neurobehavior, autonomic biomarkers, prenatal substance exposures, and socioeconomic environments. …"

Cry variables. حسب Sarah E. Maylott (14560785)

"…Understanding which infants will develop NOWS soon after birth could reduce hospital stays for infants who do not develop NOWS and decrease burdens on hospitals and clinicians. We propose noninvasive clinical indicators of NOWS, including newborn neurobehavior, autonomic biomarkers, prenatal substance exposures, and socioeconomic environments. …"

Development of (2-(Benzyloxy)phenyl)methanamine Derivatives as Potent and Selective Inhibitors of CARM1 for the Treatment of Melanoma حسب Zhihao Liu (419349)

"…In our previous study, we have identified a series of type I PRMT inhibitors, among which ZL-28-6 (<b>6</b>) exhibited increased activity against CARM1 while displaying decreased potency against other type I PRMTs. …"

Development of (2-(Benzyloxy)phenyl)methanamine Derivatives as Potent and Selective Inhibitors of CARM1 for the Treatment of Melanoma حسب Zhihao Liu (419349)

"…In our previous study, we have identified a series of type I PRMT inhibitors, among which ZL-28-6 (<b>6</b>) exhibited increased activity against CARM1 while displaying decreased potency against other type I PRMTs. …"

Development of (2-(Benzyloxy)phenyl)methanamine Derivatives as Potent and Selective Inhibitors of CARM1 for the Treatment of Melanoma حسب Zhihao Liu (419349)

"…In our previous study, we have identified a series of type I PRMT inhibitors, among which ZL-28-6 (<b>6</b>) exhibited increased activity against CARM1 while displaying decreased potency against other type I PRMTs. …"